April 20, 2023
Access & Coverage | Tea Leaves
  • The Supreme Court has temporarily extended women’s access to an abortion pill until Friday while the justices consider whether to allow restrictions on mifepristone to take effect as a legal challenge to the medication’s FDA approval continues. In an order signed by Justice Samuel Alito on Wednesday, the court indicated it will act by Friday night. (Articles here, here, here, and here)
  • The manufacturer of a generic form of the abortion pill mifepristone is suing the Food and Drug Administration in an effort to preserve access as federal litigation threatens to overturn the FDA’s approval of the drug. In a federal lawsuit filed yesterday in Maryland, drug manufacturer GenBioPro asks a judge to prohibit the FDA from taking any action that would disrupt access to the pills. GenBioPro says revoking the FDA approval of generic mifepristone would cause “catastrophic harm” to the company and to doctors and patients who rely on the drug. (Articles here, here, here, and here)